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Abstract
Background: Use of rate adaptive atrioventricular (AV) delay remains controversial in patients with biventricular
(Biv) pacing. We hypothesized that a shortened AV delay would provide optimal diastolic filling by allowing
separation of early and late diastolic filling at increased heart rate (HR) in these patients.
Methods: 34 patients (75 ± 11 yrs, 24 M, LVEF 34 ± 12%) with Biv and atrial pacing had optimal AV delay
determined at baseline HR by Doppler echocardiography. Atrial pacing rate was then increased in 10 bpm
increments to a maximum of 90 bpm. At each atrial pacing HR, optimal AV delay was determined by changing AV
delay until best E and A wave separation was seen on mitral inflow pulsed wave (PW) Doppler (defined as
increased atrial duration from baseline or prior pacemaker setting with minimal atrial truncation). Left ventricular
(LV) systolic ejection time and velocity time integral (VTI) at fixed and optimal AV delay was also tested in 13
patients. Rate adaptive AV delay was then programmed according to the optimal AV delay at the highest HR
tested and patients were followed for 1 month to assess change in NYHA class and Quality of Life Score as
assessed by Minnesota Living with Heart Failure Questionnaire.
Results: 81 AV delays were evaluated at different atrial pacing rates. Optimal AV delay decreased as atrial paced HR
increased (201 ms at 60 bpm, 187 ms at 70 bpm, 146 ms at 80 bpm and 123 ms at 90 bpm (ANOVA F-statistic =
15, p = 0.0010). Diastolic filling time (P < 0.001 vs. fixed AV delay), mitral inflow VTI (p < 0.05 vs fixed AV delay) and
systolic ejection time (p < 0.02 vs. fixed AV delay) improved by 14%, 5% and 4% respectively at optimal versus
fixed AV delay at the same HR. NYHA improved from 2.6 ± 0.7 at baseline to 1.7 ± 0.8 (p < 0.01) 1 month post
optimization. Physical component of Quality of Life Score improved from 32 ± 17 at baseline to 25 ± 12 (p < 0.05)
at follow up.
Conclusions: Increased heart rate by atrial pacing in patients with Biv pacing causes compromise in diastolic filling
time which can be improved by AV delay shortening. Aggressive AV delay shortening was required at heart rates
in physiologic range to achieve optimal diastolic filling and was associated with an increase in LV ejection time
during optimization. Functional class improved at 1 month post optimization using aggressive AV delay shortening
algorithm derived from echo-guidance at the time of Biv pacemaker optimization.
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with advanced heart failure leads to an improvement in
cardiac function during rest, exercise [1] and pharmaco-
logical stress [2]. Previous studies have shown that in
patients with CRT, optimizing atrioventricular (AV)
delay further improves stroke volume [3-6] and that
optimal AV delay changes over time requiring periodic
optimization [7]. There is controversy on optimal AV
delay at increase in heart rate with exercise. Studies
have shown conflicting data suggesting AV delay should
be prolonged [8] or shortened [9,10] as heart rate
increases. In patients with heart failure, an increase in
heart rate can compromise diastolic filling to preserve
systolic ejection [11]. This diastolic filling time can be
manipulated in heart failure patients with CRT by
adjusting AV delay at increased heart rates by using rate
adaptive algorithms of CRT devices. In this study in
patients with CRT, we evaluated a) the effect of
increased atrial pacing rate on diastolic filling at a fixed
AV delay and b) to examine the effect of manipulating
AV delay on diastolic filling. Our secondary goal was to
examine the effect of programming AV delay that pro-
vided most optimal diastolic filling at increased heart
rate on cardiac ejection acutely and on functional class
at 1 month follow up.
Methods
Study Subjects
34 heart failure patients with Biv-CRT who were atrially
pacing at resting heart rates were included in the study.
Exclusion criteria
Patients with atrial fibrillation, atrial pacing of less than
50% on pacemaker interrogation, recent hospital admis-
sion within 2 months for congestive heart failure and
acute coronary event requiring revascularization within
3 months were excluded from the study. All patients
signed an informed consent approved by the Institu-
tional Review Board. 14 patients from this study were
part of the 2 studies reported earlier [5,6].
Pacing Protocol
AV delay and interventricular (VV) delays were opti-
m i z e da tr e s tu s i n gD o p p l e re c h o c a r d i o g r a p h yb yc o n -
ventional methods. AV delay that provided that most
optimal mitral inflow filling without atrial truncation
and with best E and A separation was chosen at optimal
AV delay. Left ventricular outflow tract (LVOT) pulsed
wave (PW) Doppler was measured at rest and at each
AV delay along with pulmonary vein PW Doppler. After
optimal AV delay was determined at rest, atrial pacing
rate was increased at 10 bpm increments from baseline
heart rate of 60 or 70 bpm to a maximum of 90 bpm.
At each atrial pacing rate, mitral inflow PW Doppler
was first evaluated at the AV delay found optimal at the
previous paced atrial rate. Then the AV delay was
decreased in decrements of 20 ms until best E and A
wave separation was seen on mitral inflow without atrial
truncation. If E and A separation did not occur despite
decreasing AV delay, AV delay was increased in incre-
ments of 20 ms until E and A separation was noted.
Atrial pacing rate ranged from 60-90 beats per minute.
In 13 patients LV ejection time was also evaluated at
each paced atrial rate before and after optimal AV delay
change. PW Doppler assessment was performed 5 beats
of after change in pacemaker setting.
Echocardiography
We used transthoracic echocardiography using GE Vivid
7 or Vivid 9 ultrasound systems (Horten, Norway)
equipped with a variable frequency 2.5-5 MHz transducer
with harmonics. Echocardiogram was performed in the
left lateral decubitus position. AV delay was first opti-
mized at resting heart rate partially adopting the recent
guidelines from American Society of Echocardiography
[12]. PW Doppler sample volume placed at the tip of the
mitral leaflets for LV diastolic filling parameters. PW
Doppler sample volume was placed 0.5-1 cm below the
aortic valve at the LV outflow tract (LVOT) to obtain the
LV ejection duration and aortic velocity time integral
(VTI). Frame rate was kept above 100 fps by using single
focus, narrow imaging sector, appropriate depth and
frame rate. Parallel Doppler beam alignment to myocar-
dial segments and color Doppler was used for all Doppler
data acquisition. ECG was displayed on the ultrasound
system and 3 cardiac cycles were used for each data
acquisition. Raw data was stored digitally as DICOM cine
loops and transferred for offline analysis to a customized
dedicated workstation equipped with custom built soft-
ware (Echo PAC PC Dimension version 6.0.1, GE
Vingmed Ultrasound, Horten, Norway) via internet.
Offline Measurements
All routine chamber dimensions and LV ejection frac-
tion at baseline were measured off line. Mitral inflow
peak E and A velocities, E wave deceleration time and
mitral inflow VTI were measured at baseline and at
each paced heart rate. We also measured LVOT PW
Doppler ejection time and VTI in 13 patients at fixed
AV delay and optimal AV delay at increased atrial
pacing rates. Two blinded independent investigators
performed offline analysis of all echo data. Investigators
performing offline analysis were blinded to online
assessment of optimal AV delay settings.
Functional Class Assessment
NYHA class was evaluated at baseline and Quality of
Life was assessed by Minnesota Living with Heart
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and MHFQ were re-evaluated by a questionnaire given
to the patient in a self addressed envelope to be mailed
in at 1 month post optimization. A hall walk as toler-
ated by the patient was performed on all patients after
optimization to ensure no deterioration of exercise capa-
city from baseline.
Statistical analysis
All measurements were displayed as mean ± SD. Mea-
surements before and after optimization for AV delay
for each heart rate as well as NHYA and functional
class scores were analyzed by Paired student t- test. For
comparison of different heart rates, we used analysis of
variance (ANOVA). We used repeated measures
ANOVA for optimal measured AV delay at more than
two different heart rates. P < 0.05 was considered statis-
tically significant.
Results
34 patients were included in our study. Baseline charac-
t e r i s t i c so ft h es t u d yp o p u l a t i o na r es h o w ni nT a b l e1 .
The mean duration of CRT implant prior to optimiza-
tion was 23 ± 27 months.
Effect of Optimal AV delay Programming at Resting
Paced Atrial Rate
Change in diastolic filling and systolic ejection PW Dop-
pler parameters and on peak pulmonary artery pressure
from baseline AV delay to optimal AV delay at resting
H Ri ss h o w ni nT a b l e2 .F i g u r e1i sas t u d ye x a m p l eo f
a patient showing mitral inflow, pulmonary vein inflow
and LVOT PW Doppler measurement at baseline AV
delay and at optimal AV delay at resting HR of 60 bpm.
Increased Atrial Pacing
Patients tolerated increasing atrial pacing rate without
developing arrhythmia or hypotension. Mean duration
of atrial pacing during which Doppler echo data for dia-
stolic filling time at fixed and variable AV delays was
collected was 2 minutes. In 13 patients in whom echo
Doppler systolic ejection time before and after AV delay
optimization was also obtained, mean duration of atrial
pacing was 3 minutes.
Changes in Optimal AV Delay With Increasing Heart Rate
81 AV delays were evaluated at different atrial pacing
rates. Data on optimal AV delay at each paced heart
rate in the overall study population is shown in Table 3.
In 32 patients, optimal AV delay decreased as atrial
paced rate increased. Optimal AV delay was 201 ms at
60 bpm, 187 ms at 70 bpm, 146 ms at 80 bpm and 123
ms at 90 bpm (p = 0.001 by ANOVA for all) and is
shown in Figure 2. Repeated measures ANOVA showed
a statistically significant shortening of AV delay at three
sets of heart rates (60, 70 and 80 bpm, P < 0.001). Opti-
mal AV delay at baseline and increased paced atrial rate
in each patient is shown in Figure 3.
Effect of Optimal AV Delay on Diastolic Parameters
Data on diastolic filling time, mitral inflow VTI, E wave
deceleration time, E and A wave velocities, E/A ratio,
LVOT ejection time and LVOT VTI at various heart
rates during fixed and optimal AV delays is shown in
T a b l e4 .F i g u r e s4a n d5s h o wm i t r a li n f l o wP WD o p -
pler tracings with increased atrial pacing rate at fixed
and optimal AV delay at a heart rate of 70 bpm (Figure
4) and then 80 bpm (Figure 5) in a study patient. Abso-
lute and percent changes in PW Doppler mitral inflow
and of LVOT at fixed and optimal AV delay at 81 AV
delays tested are shown in Table 5. Diastolic filling time
was significantly longer at optimal AV delay with a
mean difference at fixed vs. optimal AV delay of 40.3 ±
25 ms, p < 0.001. Decreasing optimal AV delay with
increased heart rate was associated with an increase in
Table 1 Baseline Characteristics of the Study Population
Age 75 ± 11 years
Gender Male/Female: 24(72%)/10(28%)
NYHA 2.6 ± 0.7 - I/II/III/IV: 3%/34%/47%/
16%
NYHA 2.6 ± 0.7 - I/II/III/IV: 3%/34%/47%/
16%
Cardiomyopathy Ischemic/Non- Ischemic: 69%/
31%
QRS Duration 175.3 ± 38.6 ms
Left Ventricular Diastolic
Diameter
5.9 ± 0.93 cm
Left Ventricular Systolic Diameter 4.9 ± 1.1 cm
Left Ventricular Ejection Fraction 34.1 ± 12.4%
Left Atrial Diameter (Superior-
Inferior)
6±1c m
Left Atrial Diameter (Antero-
Posterior)
4.7 ± 0.8 cm
AV Delay 154.1 ± 40.1 (baseline)
Table 2 Effect of Biv Pacemaker Optimization on Echo
Doppler Variables at Baseline Heart Rate
Echo Doppler Variables Baseline Optmial P Value
LV Diastolic Filling Time (ms) 396 ± 75 420 ± 63 0.016
LVOT VTI (cm) 17.5 ± 4.8 19.4 ± 5.2 < 0.001
LV ejection time (ms) 287 ± 40 298 ± 36 < 0.001
Pulmonary artery pressure (mm Hg) 52 ± 7 44 ± 8 0.001
Values are Mean ± SD LV: left ventricle.; LVOT: left ventricular outflow tract;
VTI: velocity time integral
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was seen in mitral inflow deceleration time at fixed vs.
optimal AV delay. Mitral inflow A wave and E/A ratio
showed statistically significant changes after optimiza-
tion of AV delay at different heart rates (Table 4).
LVOT systolic ejection time increased at optimal vs.
fixed AV delay at increased heart rates, with a mean
change of 11 ± 15 ms (p < 0.02). A trend for an
increased in LVOT VTI was noted before and after opti-
mization (Tables 4 and 5).
Final Pacemaker Settings
Rate adaptive AV delay feature was turned ON in all
patients and AV delay shortening was programmed
according to AV delays found optimal at increased
paced heart rate in each patient. In patients with St Jude
device, AV delay settings were changed to the “most
aggressive” AV delay shortening.
25 of the patients reported an improvement in their
ability to walk immediately after optimization compared
to before optimization and 5 patients were unable to tell
Figure 1 Effect of AV delay optimization on diastolic filling. Mitral inflow (A and B), pulmonary vein inflow (C and D), and LV outflow PW
Doppler (E and F) at baseline (Apace 60 AV delay 150, LV 16 ms): A, C, and E) and optimal (A-paced 60 beats/min, AV delay 190 ms, VV0 ms: B,
D, and F) pacemaker settings. An increase in A wave duration occurred (B), and pulmonary vein pattern changed so that systolic fraction
increased, S wave deceleration time increased (D) and increased pulmonary vein atrial reversal (C) was abolished indicating reduction in left atrial
pressure. An improvement in percentage LV ejection time also occurred (F).
Table 3 Optimal AV Delay at Different Paced Atrial Rates in the Study Patients
Heart rate
(bpm)
N Optimal AV delay(ms)* 95% Confidence Interval Minimum
AV delay(ms)
Maximum
AV delay(ms)
60 9 201 ± 48 169.64-232.36 190 230
70 36 187 ± 44 172.63-201.37 100 280
80 25 146 ± 42 129.54-162.46 80 200
90 21 123 ± 49 102.04-143.96 50 250
Values are Mean ± SD
*Optimal AV delay at different heart rates (P value = 0.001 ANOVA)
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cise tolerance. NYHA improved from 2.5 ± 0.8 at base-
line to 1.7 ± 0.8 (p < 0.01) at one month post
optimization. MHFQA Failure Questionnaire was
returned at the end of one month by 20 subjects.
MHFQA improved from 49 ± 30 to 39 ± 30 (p = 0.2).
When emotional and physical components of assess-
ment were separated, a significant improvement was
noted in the physical component of quality of life from
32 ± 17 to 25 ± 12, p < 0.05.
NYHA Class by Device Manufacturer
There were 14 Medtronic devices, 7 Boston Scientific
devices and 10 St. Jude devices. Mean NYHA improve-
ment for St Jude was 0.10 compared to 0.87 for all
other brands (p = 0.068). No differences were found for
other brands.
Discussion
The salient findings of our study are that increased atrial
pacing rate causes a marked shortening of diastolic fill-
ing time at a fixed AV delay and a shortening of AV
delay at increased heart rate improves diastolic filling.
This shortening of AV delay is associated with an
improvement in LV ejection time and indirectly LV
stroke volume. Optimization of AV delay at rest and
programming of aggressive rate adaptive delay was asso-
ciated with an improvement in NYHA functional class
at 1 month follow up. The shortening of AV delay at
increased heart rates allows adequate diastolic filling
time by causing separation of early and late diastolic fill-
ing and in turn leads to an improvement in cardiac ejec-
tion as measured by LV systolic ejection time.
Aggressive shortening of AV delay at increased heart
rates is further supported by the improvement in func-
tional class that occurred in our patients at one month
follow up.
Modern pacemaker devices allow rate-response as well
as rate-adaptive AV delay shortening during exercise.
Current pacemakers do not allow AV delay lengthening
at increased heart rates. In our study the amount of AV
delay shortening needed to optimize diastolic filling was
more aggressive than current default automated pace-
maker algorithms provide. This could be related to cur-
rent rate-adaptive AV delay algorithms based on data
derived from patients with conduction abnormalities
who had otherwise preserved right ventricular and LV
systolic function whereas patients with CRT have
marked cardiac dysfunction.
We did not have a control group in whom rate adap-
tive AV delay shortening was not performed to differ-
entiate effects of optimization at resting heart rates vs.
optimization at resting heart rates and use of rate adap-
tive AV delay, however improvement in NYHA class
and quality of life in our patients suggests that program-
ming of aggressive rate adaptive delay shortening is not
deleterious, as some studies suggest, and is likely to be
beneficial. We selected patients who were atrial pacing
in addition to Biv pacing at baseline since a constant
heart rate provided by atrial pacing allowed patients to
act as their own control in whom fixed versus shortened
AV delay effects in a given cardiac cycle of constant
length could be tested.
In humans with normal cardiac function, there is
decreasing AV delay with increasing heart rate in a pre-
dictable manner (4 ms/10 bpm). Patients with dilated
Figure 2 Effect of increasing paced atrial rate on optimal AV delay in the study population.
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abnormal shortening of LV diastole at rest [13] that is
accentuated during exercise [11]. In addition, abnormal
shortening of LV diastolic time requires higher left atrial
pressures to maintain LV filling during exercise resulting
in pulmonary congestion and exercise intolerance
[10,12]. Although previous studies showed the impor-
tance of periodically optimizing AV delay [14] there is
insufficient data on changes in AV delay with pacing at
various heart rates. These studies are summarized in
Table 6. Scharf et al [8] attributed probable longer dia-
stolic filling with prolonging of AV delay that caused an
improvement in LVOT VTI. However physiologically,
prolongation of AV delay should lead to approximation
of E and A waves due to pushing back of atrial contrac-
tion towards early diastole when early diastolic filling (E
wave on PW Doppler) occurs. Calculation of AV delay
Figure 3 Optimal AV delay at increased paced atrial heart rates during biventricular pacing in each study patient.
Table 4 Echo Doppler Measurements Before and After
Optimization During Atrial Pacing Above Baseline Heart
Rate
Echo Doppler
Variables
Before
Optimization
After
Optimization
P
value
Diastolic filling time
(ms)
279 ± 60 318 ± 43 < 0.001
Mitral inflow VTI (cm) 14.9 ± 5.7 15.8 ± 4.7 0.04
E wave (cm/s) 0.71 ± 0.30 0.72 ± 0.25 0.33
A wave (cm/s) 0.70 ± 0.29 0.64 ± 0.26 0.01
E/A 1.13 ± 0.51 1.27 ± 0.65 < 0.001
Systolic ejection time
(ms)
276 ± 37 285 ± 38 0.011
LVOT VTI (cm) 14.7 ± 3.8 15.5 ± 3 .21
Values are Mean ± SD. LVOT: left ventricular outflow tract; VTI: velocity time
integral
Rafie et al. Cardiovascular Ultrasound 2012, 10:2
http://www.cardiovascularultrasound.com/content/10/1/2
Page 6 of 11immediately after exercise with unstable heart rates may
have confounded their results.
Recent study by Mokrani et al [15] found that variable
changes in optimal AV delay were needed during exer-
cise when using LVOT VTI and diastolic filling time in
patients. Changing heart rates during Doppler assess-
ment may have led to variable results. Study by Valzania
et al found variation in VV delay from rest to exercise
but no significant changes in AV delay using LVOT
VTI to optimize AV delay during rest and exercise [16].
Contrary to findings of these earlier studies, several
other studies found that shortening of AV delay is
needed at increased heart rates. Melzer et al [9] found
that optimal AV delay was shorter with increasing heart
rate during DDD (atrial-paced Biv pacing) pacing and
not during VDD (atrial-sensed Biv-pacing) pacing during
exercise. All patients included in this study were respon-
ders by NYHA class and were enrolled 6 months post
CRT. To calculate optimal AV delay, interatrial conduc-
tion time (time between atrial stimulus and left atrial
deflection), left atrial electromechanical time (time
between left atrial deflection and the end of the A wave
on mitral diastolic filling) and LV latency period (time
between ventricular pacing stimulation and end of trun-
cated A wave on programming the pacemaker at a non-
physiologic short AV delay) were measured. During
exercise, interatrial conduction time and LV latency per-
iod did not change significantly but left atrial electrome-
chanical action decreased significantly with patients in
the DDD mode. Thus stable electrical conduction time
but variable diastolic filling time at different heart rates
was found in this study.
Whinnett et al [17] determined optimal AV delay at
rest and during exercise using non invasive finger arter-
ial pressure measurements. Their results showed short-
ening of AV delay at increased heart rate in 11 patients
while 8 patients needed lengthening of AV delay. Mea-
surements of optimal AV delay at three different phases
as described above at rest could predict the exercise
optimal AV delay with good agreement (r = 0.85), how-
ever only using optimal AV delay during atrial sensing
at rest was less reliable in predicting optimal AV delay
Figure 4 Increased atrial pacing rate requires progressive shortening of AV delay. After baseline AV delay optimization shown in Figure 1,
atrial pacing rate was increased to 70 beats/min, and AV delay was kept fixed at 190 ms. Marked E and A fusion developed (A). AV delay was
then progressively shortened to 120 ms until E and A separation occurred (C). Hence, optimal AV delay at a paced atrial rate of 70 beats/min
was 120 ms.
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Page 7 of 11at increased heart rates. The study showed predictive
value of atrial pacing at rest for optimal exercise AV
delay.
Tse et al [18] evaluated changes in AV delay in CRT
patients during exercise treadmill test using mitral
inflow PW Doppler parameters. AV delay optimization
by echocardiography provided the longest mitral filling
time without truncation of A wave. 55% of patients had
severe chronotropic incompetence and achieved < 70%
age-predicted heart rate during exercise. These patients
showed increased peak exercise heart rate, exercise time
and peak oxygen consumption by appropriate use of
rate-adaptive pacing.
Our study differs from these earlier studies in that our
study population is older, on average by 10 years, had a
higher NYHA class, most were unable to perform more
than mild exercise and all were DDD pacing indicating
conduction system disease. In addition ours is the only
study which was not only observational but rate adap-
tive AV delay was programmed according to findings of
optimal AV delay and increased atrial pacing rate.
Another differentiating feature of our study that 32 of
our 34 patients required a decrease in AV delay with
Figure 5 Increased Atrial Pacing Rate Requires Progressive Shortening of AV delay. After optimization AV delay at atrial pacing rate of 70
bpm in the same patient as shown in Figure 4, paced atrial rate was then increased to 80 beats/min at the AV delay of 120 ms. Marked E and
A fusion developed again (A). Progressive shortening of AV delay to 90 ms (B), and then 80 ms (C) caused mitral inflow E and A separation.
Further shortening of AV delay to 70 ms (D) led to shortening of mitral inflow A-wave and premature closure of mitral valve. Hence, optimal AV
delay at a paced atrial rate of 80 bpm was 80 ms.
Table 5 Effect of Fixed versus Optimal AV Delay on Echo
Doppler Parameters at Increased Atrial Pacing Rates
Echo Doppler Variable Δ Fixed vs. Opt AV
Delay
%
Δ
P
Diastolic Filling Time (ms) 40.2 ± 25 14 < 0.001
Mitral inflow VTI (cm) 0.92 ± 2 5 0.04
Systolic Ejection Time (ms, n
= 13)
11 ± 15 4 0.011
LVOT VTI (cm, n = 13) 0.56 ± 1.6 3 0.21
Values are Mean ± SD or percent change
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Page 8 of 11Table 6 Prior Studies That Evaluated the Effect of Increased Heart Rate on Optimal Atrioventricular Delay in Patients
with CRT
Author N Study
Population
Heart rate tested How HR Increased Method to calculate
Opt AV Delay
Optimal AV Delay at
Increased Heart Rate
Melzer et
al
20 CRTresponder
64 ± 10 yrs,
NYHA < 3. VDD
and DDD mode
used. EF 23.2 ±
7.6
22.5 ± 9.6 bpm above
baseline Supine bicycle
ergometer beginning with
25 W and increasing the
workload by 25 W every 2
min. (71+9 W).
Supine bicycle exercise Combination of mitral
inflow PW Doppler,
trans-esophagel left
atrial electrograms and
surface ECG.
No AV delay change
needed in VDD mode. With
DDD mode, optimal AV
delay was shortened by 2.6
ms/10 bpm
Scharf et
al
36 Biv-ICD, 62 ± 8
yrs, EF 17 ± 5
Pacing heart rate increased
to 110-120 bpm and with
exercise increase in intrinsic
heart rate at least 20 bpm
above baseline. Optimal AV
Delay determined post
exercise
DDD pacing or treadmill
exercise In 22 patients with
DDD HR increased to 110-
120 bpm. In 14 patients
with exercise HR increased
at least 20 bpm above
baseline
LVOT VTI post exercise Prolongation of AV delay
found optimal at increased
HRs. An increase in LVOT
VTI of 0.047 cm/s per 20 ms
prolongation of AV delay
per 10 bpm increase in
heart rate for DDD pacing
and 0.146 cm/s increase in
VTI per 20 ms prolongation
of AV delay per 10 bpm
increase in heart rate during
exercise. Beneficial effect of
AV delay prolonging was
observed until heart rate
110 bpm.
Grimm R
et al
15 CRT patients
without atrial
pacing who
were able to
exercise, 57 ±
16 yrs, EF 37 ±
15
Atrial-sensed Biv pacing, HR
20-40 bpm above baseline
Supine bicycle exercise Maximum LV filling
time. The duration of
LV filling, stroke
volume, and a clinical
assessment of LV
function were studied.
AV delay shortening
needed at increased HR for
all patients using three
independent criteria.
Consistent trends were
observed between all three
parameters for 12 out of
the 15 patients.
Mokrani B
et al
50 CRT patients
who were able
to exercise, 69 ±
7 yrs, EF 25 ± 7
Atrial-sensed Biv pacing,
60% of the maximal
predicted. HR, with the
sensed AV delay set at 40,
70, 100, 120, 150, and 200
ms. Only 1 maximum HR
tested.
Supine bicycle exercise LVOT VTI, LV filling
time
Optimal AV delay based on
LVOT-VTI was shorter during
exercise than at rest in 37%,
unchanged in 37%, and
longer in 26% of patients.
The optimal AV delay based
on mitral inflow filling time
was shorter during exercise
than at rest in 27%,
unchanged in 23%, and
longer in 50% of patients.
Opt-imization of AV delay
during exercise inc-reased
LV filling time and LVOT-VTI
(P < .05)
Valzania
Ce ta l
24 CRT patients
able to exercise,
63 ± 9 yrs, EF
36 ± 9
Atrial-sensed Biv pacing, 20-
beat increase in HR above
baseline. Only 1 maximum
HR tested.
Supine bicycle exercise LVOT VTI by PW
Doppler and
automated intra-
cardiac electrogram
(IEGM)to optimize AV
delay and VV delay
Optimal VV delay varied
considerably from rest to
exercise, while AV delay did
not change. A substantial
agreement in deriving
optimized AV delays was
observed between the
echocardiogram and the
IEGM method, both at rest
and during exercise.
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was more aggressive than found by previous studies. We
used atrial pacing at incremental heart rates in the phy-
siologic range to mimic heart rates expected to be
achieved in these patients during physiologic exercise.
Our study also differs from above studies that we used
mitral inflow and LVOT Doppler as well as pulmonary
vein Doppler echocardiography to determine optimal
AV delay at resting heart rates. In addition we showed
in a subset of our study patient’s improved systolic ejec-
tion time at optimal shortened versus fixed AV delays at
increased heart rates. Above all we showed improve-
ment in functional class as a result of pacemaker
changes including use of dynamic rate adaptive AV
delay shortening as determined by our pacing protocol.
The differences in NYHA class improvement show a
trend to lower improvement in patients with St Jude
device. This is likely due to a different AV delay short-
ening algorithm in St Jude devices that does not allow
AV delay shortening until a heart rate of 90 bpm and at
that heart rate is programmable at 1-, 2-, or 3-ms short-
ening per 1 beat/min in rate (low, normal, high) vs. lin-
ear response between shortest heart rate and maximum
heart rate for other devices. Given no other significant
differences between manufacturer algorithms, this sug-
gests that rate adaptive AV delay shortening is an
important element in pacemaker programming.
Our finding suggest that individualized pacemaker
optimization should be performed at rest and at
increased heart rates and more aggressive shortening of
the AV delay should be used as default pacemaker
setting in most devices in patients with CRT who are in
the atrial pacing Biv pacing mode (DDD pacing).
Limitations
Atrial pacing that may be less physiologic than intrinsic
increase in atrial rate during exercise hence our findings
may not apply to patients with predominant atrial sen-
sing. Our use of dynamic AV delay shortening as deter-
mined by atrial pacing was limited by device algorithms
by different manufacturers. We did not perform invasive
study to assess stroke volume changes with various AV
delay at different heart rates.
We evaluated functional class by NYHA and quality of
life questionnaire and did not perform follow up echo-
cardiographic assessment. However we do not anticipate
a significant change in LVEF over time given prolonged
time period since pacemaker implant. While improve-
ment in functional class may have been subjective, it
likely was a result of pacemaker optimization since no
changes occurred in medications or medical or cardiac
condition in our patients. Finally our study is not rando-
mized that would allow true impact of rate adaptive AV
delay change. Such a study should be performed.
Conclusion
Our data suggests that an individualized pacemaker pro-
gramming should be performed. In most patients with
CRT an increase in heart rate causes a compromise in
diastolic filling which can be improved with a significant
shortening of AV delay at increased pacing rates.
Aggressive AV delay shortening as determined by acute
Table 6 Prior Studies That Evaluated the Effect of Increased Heart Rate on Optimal Atrioventricular Delay in Patients
with CRT (Continued)
Whinnett
ZI et al
20 CRT patients
who were able
to exercise, 68
yrs(46-82 yrs)
Atrial-sensed Biv pacing, HR
of 100 bpm with exercise.
Pacing at rest at 5 bpm
above resting rate and at
100 bpm. Sensed-paced
difference, calculated as an
“expected” value for the
exercise optimum.
Treadmill exercise Noninvasive finger
arterial pressure
measurements using a
Finometer
Hemodynamic optimization
of AV delay under three
different conditions before
exercise. The resting three-
phase model correlated
well with the actual
exercise optimal AV delay (r
= 0.85, mean difference ±
standard [SD] = 3.7 ± 17
ms). In 11 patients, the
optimal AV delay was
shorter during exercise than
at rest, in eight patients it
was longer and in 1 patient,
unchanged.
Tse
Hung-Fat
et al
20 CRT patients
who were able
to exercise, 65 ±
4 yrs, EF 27 ± 3
AV delay adaptive algorithm,
maximum programmed
equal to the optimal resting
AV delay during atrial
pacing and the minimum
AV delay to the optimal
resting AV delay during
atrial pacing–50 bpm in 10-
ms decrements.
Cardiopulmonary treadmill
exercise
Longest LV filling time
without truncation of
the A wave from mitral
inflow PW Doppler
In heart failure patients with
severe chronotropic
incompetence as defined
by failure to achieve < 70%
target HR, appropriate use
of rate-adaptive pacing with
CRT provides incremental
benefit on exercise capacity
during exercise.
Rafie et al. Cardiovascular Ultrasound 2012, 10:2
http://www.cardiovascularultrasound.com/content/10/1/2
Page 10 of 11atrial pacing protocol was associated with a significant
improvement in functional class post CRT.
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